Hinge Health, Inc. (HNGE) Financial Ratios
3 years of historical data (2023–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
30.14
↑+36% vs avg
5yr avg: 22.23
30Y Low22.2·High22.2
P/B Ratio
14.10
↑+41% vs avg
5yr avg: 10.02
30Y Low10.0·High10.0
ROE
↓
-132.9%
↑-148% vs avg
5yr avg: -53.7%
30Y Low-133%·High-3%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
HNGE Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Hinge Health, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 30.1x P/FCF, 36% above the 5-year average of 22.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Market Cap | $5.1B | $3.8B | — | — |
| Enterprise Value | $4.9B | $3.6B | — | — |
| P/E Ratio → | -12.59 | — | — | — |
| P/S Ratio | 8.75 | 6.46 | — | — |
| P/B Ratio | 14.10 | 10.02 | — | — |
| P/FCF | 30.14 | 22.23 | — | — |
| P/OCF | 30.02 | 22.13 | — | — |
P/E links to full P/E history page with 30-year chart
HNGE EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| EV / Revenue | — | 6.12 | — | — |
| EV / EBITDA | — | — | — | — |
| EV / EBIT | — | — | — | — |
| EV / FCF | — | 21.06 | — | — |
HNGE Profitability
Margins and return-on-capital ratios measuring operating efficiency
Hinge Health, Inc. earns an operating margin of -92.9%. Operating margins have compressed from -44.6% to -92.9% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -132.9% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Gross Margin | 79.6% | 79.6% | 77.0% | 66.3% |
| Operating Margin | -92.9% | -92.9% | -6.3% | -44.6% |
| Net Profit Margin | -89.9% | -89.9% | -3.1% | -36.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ROE | -132.9% | -132.9% | -2.8% | -25.3% |
| ROA | -74.5% | -74.5% | -1.8% | -17.4% |
| ROIC | -268.2% | -268.2% | -10.9% | -47.0% |
| ROCE | -135.5% | -135.5% | -5.7% | -29.8% |
HNGE Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $208M exceeds total debt of $8M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.03 | 0.04 |
| Debt / EBITDA | — | — | — | — |
| Net Debt / Equity | — | -0.53 | -0.70 | -0.51 |
| Net Debt / EBITDA | — | — | — | — |
| Debt / FCF | — | -1.17 | -6.41 | — |
| Interest Coverage | — | — | — | — |
Net cash position: cash ($208M) exceeds total debt ($8M)
HNGE Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.47x means Hinge Health, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.88x to 1.47x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Current Ratio | 1.47 | 1.47 | 2.34 | 2.88 |
| Quick Ratio | 1.43 | 1.43 | 2.30 | 2.81 |
| Cash Ratio | 1.00 | 1.00 | 1.87 | 2.30 |
| Asset Turnover | — | 0.79 | 0.58 | 0.47 |
| Inventory Turnover | 7.65 | 7.65 | 8.26 | 7.41 |
| Days Sales Outstanding | — | 41.02 | 39.73 | 58.06 |
HNGE Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Hinge Health, Inc. returns 1.3% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Dividend Yield | — | — | — | — |
| Payout Ratio | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Earnings Yield | — | — | — | — |
| FCF Yield | 3.3% | 4.5% | — | — |
| Buyback Yield | 1.3% | 1.7% | — | — |
| Total Shareholder Yield | 1.3% | 1.7% | — | — |
| Shares Outstanding | — | $82M | $78M | $78M |
Peer Comparison
Compare HNGE with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 HNGEYou | $5B | -12.6 | — | 30.1 | 79.6% | -92.9% | -132.9% | -268.2% | — |
 OMCL | $2B | 854.0 | 20.6 | 19.8 | 42.5% | 0.4% | 0.2% | 0.3% | 2.4 |
 TDOC | $1B | -6.4 | 15.8 | 4.6 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 HIMS | $6B | 52.6 | 43.2 | 79.6 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 DOCS | $4B | 20.4 | 16.5 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 |
 AMWL | $152M | -1.5 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 OPRX | $98M | 19.4 | 6.2 | 5.3 | 63.3% | 11.0% | 4.2% | 6.8% | 1.6 |
 TALK | $873M | 130.3 | 138.6 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 UNH | $371B | 30.9 | 18.2 | 23.1 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $130B | 73.4 | 14.4 | 16.7 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 CI | $79B | 13.4 | 8.7 | 9.4 | 9.5% | 3.3% | 14.3% | 10.4% | 2.7 |
| Healthcare Median | — | 22.9 | 14.4 | 18.9 | 63.9% | -4.3% | -32.6% | -11.4% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 3 years · Updated daily
What if you invested $1,000 in HNGE 10 years ago?
Total return calculator · dividends reinvested
Calculate ReturnsHow much would $100/month in HNGE be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs HNGE Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationHNGE vs OMCL — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Omnicell, Inc..
Compare NowHNGE — Frequently Asked Questions
Quick answers to the most common questions about buying HNGE stock.
What is Hinge Health, Inc.'s P/E ratio?
Hinge Health, Inc.'s current P/E ratio is -12.6x. This places it at the 50th percentile of its historical range.
What is Hinge Health, Inc.'s ROE?
Hinge Health, Inc.'s return on equity (ROE) is -132.9%. The historical average is -53.7%.
Is HNGE stock overvalued?
Based on historical data, Hinge Health, Inc. is trading at a P/E of -12.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Hinge Health, Inc.'s profit margins?
Hinge Health, Inc. has 79.6% gross margin and -92.9% operating margin.